A9607 Lutetium lu 177 vipivotide
A-Codes
Also known as: Pluvicto, Lu-177 PSMA, vipivotide
Lutetium Lu-177 vipivotide tetraxetan injection used therapeutically for treatment of prostate cancer expressing prostate-specific membrane antigen.
Clinical Context
Used in targeted radiotherapy for treatment of metastatic castration-resistant prostate cancer with prostate-specific membrane antigen expression.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.